Omniox Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Omniox Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014205
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Omniox Inc (Omniox) is a biotechnology company that develops new medicines for hypoxic diseases. The company’s H-NOX products are tailored for the treatment of hypoxic cancers, which include giloblastoma, metastatic brain cancer, head-and-neck cancer, pancreatic cancer, lung cancer, and prostate cancer in combination with standard of care radiation and chemotherapy. It provides engineering of unusually stable oxygen carrier technology to deliver oxygen into hypoxic tissues and improve the treatment of severe unmet medical needs. Its OMX-4.80P delivers oxygen into the tumor microenvironment. The company offers solutions for cure of impacts of cancer, cardiovascular diseases, trauma and other conditions. Omniox is headquartered in San Carlos, California, the US.

Omniox Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Omniox Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Omniox Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Omniox Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Omniox Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Omniox Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Omniox Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Omniox Raises USD4.7 Million in Venture Financing 10
Omniox Raises USD6.6 Million in Venture Financing 11
Omniox Raises US$3 Million In Venture Financing 12
Omniox Raises US$1 Million In Venture Financing 13
Omniox Inc – Key Competitors 14
Omniox Inc – Key Employees 15
Omniox Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Clinical Trials 17
Nov 17, 2016: Omniox presents preclinical data on immuno-sensitizing effects of OMX-4.80P in orthotopic glioblastoma tumors at the CNS Anti-Cancer Drug Discovery Conference and 21st Annual Society for Neuro-Oncology Meeting in Scottsdale, Arizona 17
Sep 26, 2016: Omniox presents preclinical data on OMX-4.80P’s immunostimulatory effects in hypoxic tumors at the CTI-CIMT-EATI-AACR 2nd International Cancer Immunotherapy Conference in New York, NY 18
Apr 20, 2016: Omniox presents preclinical data on OMX-4.80P as a cancer immunotherapy at the 2016 Annual Meeting of the American Association for Cancer Research in New Orleans, LA 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Omniox Inc, Pharmaceuticals & Healthcare, Key Facts 2
Omniox Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Omniox Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Omniox Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Omniox Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Omniox Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Omniox Raises USD4.7 Million in Venture Financing 10
Omniox Raises USD6.6 Million in Venture Financing 11
Omniox Raises US$3 Million In Venture Financing 12
Omniox Raises US$1 Million In Venture Financing 13
Omniox Inc, Key Competitors 14
Omniox Inc, Key Employees 15

★海外企業調査レポート[Omniox Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Flex Ltd (FLEX):企業の財務・戦略的SWOT分析
    Flex Ltd (FLEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Sentara Healthcare Inc:企業の戦略的SWOT分析
    Sentara Healthcare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Transgenomic Inc (TBIO)-医療機器分野:企業M&A・提携分析
    Summary Transgenomic Inc (Transgenomic) is a developer and provider of diagnostic tools and services. The company’s products include ICEme Kits, and genetic assays and platforms. It offers genetic assays and platforms such as PCR reagents, chromatography, genetic analysis kits, hanabi cytogenetic sy …
  • Shin Poong PharmCo Ltd (019170):製薬・医療:M&Aディール及び事業提携情報
    Summary Shin Poong PharmCo Ltd (Shin Poong) is a contract manufacturing company that manufactures and markets pharmaceutical products and active pharmaceutical ingredients. The company provides drugs such as psychoneurotic, anti-cancer, cardiovascular, antihistamine, antirheumatic and benign prostat …
  • Rich Pharmaceuticals Inc (RCHA):製薬・医療:M&Aディール及び事業提携情報
    Summary Rich Pharmaceuticals Inc (Rich Pharmaceuticals) is a biopharmaceutical company that offers discovery and development of therapies for the treatment of acute myelogenous leukemia (AML) in refractory patients. The company’s pipeline portfolio offers a lead drug candidate for the treatment of a …
  • Mediclinic International Plc (MDC):製薬・医療:M&Aディール及び事業提携情報
    Summary Mediclinic International Plc (Mediclinic), formerly Al Noor Hospitals Group Plc is a healthcare service provider. The center offers services such as specialist-orientated, acute-care and multi disciplinary healthcare services. It also provides clinical services such as pre hospital emergency …
  • Export Development Canada-エネルギー分野:企業M&A・提携分析
    Summary Export Development Canada (EDC) is an export credit agency that provides financial services. The agency supports and promotes Canada’s export trade by providing finance and insurance solutions to companies with export contracts. It provides guarantees to banks to provide their exporting cust …
  • curasan AG (CUR):企業の財務・戦略的SWOT分析
    curasan AG (CUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Toho Holdings Co Ltd (8129):企業の財務・戦略的SWOT分析
    Toho Holdings Co Ltd (8129) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Suncorp Group Ltd:企業の戦略・SWOT・財務分析
    Suncorp Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Suncorp Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Towngas China Co Ltd (1083):企業の財務・戦略的SWOT分析
    Summary Towngas China Co Ltd (Towngas China), a subsidiary of The Hong Kong and China Gas Co Ltd is an oil and gas company. The company's business activities include sale and distribution of pipeline gas, gas pipeline construction, operation of city-gas pipeline networks, operating fuel automobile r …
  • Interprotein Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Interprotein Corp (Interprotein) is a drug development company that develops active modulators for protein-protein interaction (PPI) targets. The company offers products such as IL-6 inhibitor, IgE inhibitor, notch1 inhibitor, tubulin polymerization inhibitors, TIM-3 inhibitor, NKG2A, HLA-E …
  • Sonangol EP:企業のM&A・事業提携・投資動向
    Sonangol EP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sonangol EP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Williams Partners LP:企業のM&A・事業提携・投資動向
    Williams Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Williams Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Allianz France S.A.:企業の戦略・SWOT・財務情報
    Allianz France S.A. - Strategy, SWOT and Corporate Finance Report Summary Allianz France S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Energinet.dk:企業の戦略的SWOT分析
    Energinet.dk - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Axel Springer SE:企業の戦略・SWOT・財務情報
    Axel Springer SE - Strategy, SWOT and Corporate Finance Report Summary Axel Springer SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Epic Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Epic Sciences Inc (Epic Sciences) focuses to develop novel diagnostics for personalized treatment of cancer. The company develops AR-V7 test to identify and molecularly characterize circulating tumor cells in a blood sample. It also offers biopharma solutions such as resistance to AR signali …
  • Precision Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Precision Biologics Inc (PBI), a subsidiary of NantWorks LLC, is a clinical stage biotechnology company. The company offers cancer vaccines, antigens and antibodies, pipelines, diagnostics, therapeutics, clinical trials, tumor specific antigens, companion diagnostic programs, and diagnostic …
  • Antero Resources Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Antero Resources Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Antero Resources Corp (Antero) is an independent oil and natural gas company that explores, develops, produces and sells natural gas and oil from the Appalachia Basin. It gather and process wel …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆